Aerin Medical Secures $60 Million in Equity Financing

Ally Bridge Group joins existing syndicate of KCK MedTech, Questa Capital and OrbiMed SUNNYVALE, Calif.–(BUSINESS WIRE)–Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced it has recently closed a $60 million equity financing. The financing was led by … [Read more…]

Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform

COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a digital health leader revolutionizing chronic care, today announced that the company’s 31st patent was granted on June 14, 2022, demonstrating the continued advancement of Welldoc’s first-in-class technology for comprehensive chronic condition management. Welldoc’s portfolio includes patents from the U.S. Patent and Trademark Office and IP Australia. “The expansion of Welldoc’s IP … [Read more…]

Rubric Capital Management Sends Letter to Radius Health Board of Directors

Outlines Value Enhancing Initiatives to Address Company’s Underperformance and Poor Corporate Governance Intends to Support Velan-Repertoire Director Slate at Upcoming Annual Meeting NEW YORK–(BUSINESS WIRE)–Rubric Capital Management LP (“Rubric”), an investment advisor whose funds and accounts collectively own approximately 14.62% of the common stock of Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS), today … [Read more…]

IntelyCare Announces 900,000 Enrollments in IntelyEdu, Empowering Nursing Professionals With Affordable, Innovative Access to Continuing Education

IntelyEdu breaks down education barriers by providing nursing continuing professional development (NCPD) credits and career advancement opportunities through on-demand learning and exclusive partnerships QUINCY, Mass.–(BUSINESS WIRE)–#CE–IntelyCare, the leading tech-enabled nurse staffing platform for healthcare organizations in the United States, today announced the formal launch of IntelyEdu, its continuing education platform that already has 900,000 enrollments. … [Read more…]

Comera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial Officer

WOBURN, Mass.–(BUSINESS WIRE)–Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced the appointment of Michael Campbell as Executive Vice President and Chief Financial Officer. He had served as interim Chief Financial Officer since April 13, 2022 … [Read more…]

Apnimed Adds Ruoxi Hu, Ph.D., From Morningside Technology Advisory to Its Board of Directors

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, announced today that Ruoxi (Rosy) Hu, Ph.D., from Morningside Technology Advisory, LLC has been appointed to the company’s Board of Directors. Dr. Hu replaces Jay Galeota, who recently stepped down from the Board. … [Read more…]

Navitus Health Solutions 2021 Drug Trend Report Reveals Significant Cost Savings and Improved Member Health

MADISON, Wis.–(BUSINESS WIRE)–Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) that’s committed to bringing humanity to pharmacy benefits management, released its 2021 Annual Drug Trend Report demonstrating pharmacy benefit cost savings for its customers and improved affordability for members. Navitus’ new report shows that new clients who moved to Navitus from another PBM in … [Read more…]

Koneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease

NEW YORK–(BUSINESS WIRE)–#MJFF—Koneksa, a healthcare technology company pioneering digital biomarkers, announced today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) in collaboration with Northwestern University. The research study will evaluate a measurement concept that is designed to objectively quantify the severity of symptoms related to … [Read more…]

Pear Therapeutics to Participate in the Cowen 7th Annual FutureHealth Conference

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in Cowen’s 7th Annual FutureHealth Conference, a virtual event taking place June 22 – June 23, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a panel discussion … [Read more…]

Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer

WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced the appointment of Kelley Dealhoy as Senior Vice President and Chief Business Officer. Ms. Dealhoy brings 20 years of life science leadership experience to the role, and her responsibilities will include developing and leading the Company’s business development efforts as well as supporting corporate strategy initiatives. … [Read more…]